share_log

Clearmind Medicine Receives New Patent Approval From US Patent And Trademark Office, Marking Significant Advancement In Its Proprietary MEAI-Based Binge Behavior Regulator Program

Clearmind Medicine Receives New Patent Approval From US Patent And Trademark Office, Marking Significant Advancement In Its Proprietary MEAI-Based Binge Behavior Regulator Program

Clearmind Medicine获得来自美国专利和商标局的新专利批准,标志着其基于MEAI的暴食行为调节剂计划取得了重大进展。
Benzinga ·  08/21 16:12

Clearmind Medicine Receives New Patent Approval From US Patent And Trademark Office, Marking Significant Advancement In Its Proprietary MEAI-Based Binge Behavior Regulator Program

Clearmind Medicine获得来自美国专利和商标局的新专利批准,标志着其基于MEAI的暴食行为调节剂计划取得了重大进展。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发